Open label, Phase I study to assess and compare the pharmacokinetic parameters after multiple oral administration of stiripentol 1000 mg in renal impaired patients and matching controls with normal renal function

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516655-40-00

Acronym

STP237

Enrollment

Registered

2024-11-27

Start date

2023-06-02

Completion date

2024-11-30

Last updated

2024-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with renal impairement

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria

None listed

Source: EU CTIS · Data processed: Feb 4, 2026